PD-1抑制剂-话题@MedSci

#PD-1抑制剂#

52篇内容 | 2932人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1278921, encodeId=680b12e892174, content=<a href='/topic/show?id=70e6139138a' target=_blank style='color:#2F92EE;'>#PD-1抑制剂#</a>, objectTitle=市场能容纳多少PD-1抑制剂？, objectType=article, longId=44609, objectId=6b384460923, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6b384460923, replyNumber=0, likeNumber=62, createdTime=2014-12-27, rootId=0, userName=xiongliangxl, userId=84fb152, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6b384460923, moduleTitle=市场能容纳多少PD-1抑制剂？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6b384460923)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1278920, encodeId=daaa12e89201a, content=<a href='/topic/show?id=70e6139138a' target=_blank style='color:#2F92EE;'>#PD-1抑制剂#</a>, objectTitle=FDA提前三个月批准施贵宝PD-1抑制剂Nivolumab(Opdivo)，与Keytruda同价, objectType=article, longId=44538, objectId=2d0144538df, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2d0144538df, replyNumber=0, likeNumber=69, createdTime=2014-12-26, rootId=0, userName=xiongliangxl, userId=84fb152, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2d0144538df, moduleTitle=FDA提前三个月批准施贵宝PD-1抑制剂Nivolumab(Opdivo)，与Keytruda同价, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2d0144538df)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1278919, encodeId=038f12e891995, content=<a href='/topic/show?id=70e6139138a' target=_blank style='color:#2F92EE;'>#PD-1抑制剂#</a>, objectTitle=回眸一笑百媚生：PD-1抑制剂nivolumab延长黑色素瘤患者生存期, objectType=article, longId=42706, objectId=31cd42e06ce, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=31cd42e06ce, replyNumber=0, likeNumber=64, createdTime=2014-11-19, rootId=0, userName=xiongliangxl, userId=84fb152, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=31cd42e06ce, moduleTitle=回眸一笑百媚生：PD-1抑制剂nivolumab延长黑色素瘤患者生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=31cd42e06ce)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1278918, encodeId=66a412e8918e6, content=<a href='/topic/show?id=70e6139138a' target=_blank style='color:#2F92EE;'>#PD-1抑制剂#</a>, objectTitle=时美PD-1抑制剂Opdivo欧美监管收获好消息, objectType=article, longId=40989, objectId=76fb40989e4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=76fb40989e4, replyNumber=0, likeNumber=60, createdTime=2014-10-10, rootId=0, userName=xiongliangxl, userId=84fb152, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=76fb40989e4, moduleTitle=时美PD-1抑制剂Opdivo欧美监管收获好消息, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=76fb40989e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

PD-1抑制剂

2020-05-29

xiongliangxl (审核中...)

前往app查看评论内容

#PD-1抑制剂#

市场能容纳多少PD-1抑制剂？

2014-12-27

xiongliangxl (审核中...)

前往app查看评论内容

#PD-1抑制剂#

FDA提前三个月批准施贵宝PD-1抑制剂Nivolumab(Opdivo)，与Keytruda同价

2014-12-26

xiongliangxl (审核中...)

前往app查看评论内容

#PD-1抑制剂#

回眸一笑百媚生：PD-1抑制剂nivolumab延长黑色素瘤患者生存期

2014-11-19

xiongliangxl (审核中...)

前往app查看评论内容

#PD-1抑制剂#

时美PD-1抑制剂Opdivo欧美监管收获好消息

2014-10-10

科室
- - 订阅+
  - 更多科室
工具
服务